Loading showcase...
Loading showcase...


Personalised diagnostics powered by AI
Building AI-designed PCR tests that tells clinicians which antibiotics will work against a patient’s infection in hours, not the 2–3 days culture testing takes. Our explainable AI predicts resistance from bacterial genomes, and its markers go into a single-use kit that runs on instruments hospitals already own. Antimicrobial resistance kills 1.27 million people a year; faster, correct first prescribing saves lives and antibiotics.
Hospitals wait 24–72 hours for culture-based susceptibility results, so clinicians start with a best-guess broad-spectrum antibiotic. Studies suggest around 60% of empirical prescriptions are incorrect. Wrong or delayed therapy raises mortality, lengthens stays, costs the NHS an estimated £150M a year and drives further resistance.
We combine three layers no one else joins up. Archeion maps each bacterial species to find resistance markers. Phylax, our explainable AI trained on 106,539 genomes, predicts which antibiotics will work and which genes drive each prediction. The best markers go into a targeted PCR panel that gives a per-antibiotic answer in hours on existing lab hardware, with no sequencer. Results feed back as training data, and our open AMR benchmark sets a standard for validation.
Tech Stack
Key Highlights
Sign in to share feedback, ask questions, and support this startup.
Sign in to commentNo comments yet. Be the first to share your thoughts!
Founder & CEO
£750k Innovate UK grant. Three angel investments SAFEs executed. Advisory and leadership team estabblished.